Non-Clinical Toxicology and safety assessment of a small molecule
At a glance
Helmholtz-Zentrum für Infektionsforschung GmbH is procuring Research and experimental development services (CPV 73100000) in Braunschweig, Kreisfreie Stadt (DE911). The notice gives 7 December 2026, 10:00 (UTC+01:00) as the deadline. Procedure type: Open.
From the notice
The overall objective of the present project is to conduct a comprehensive nonclinical toxicology and safety assessment program for a small-molecule drug candidate. The program is intended to characterize the toxicological and safety pharmacology profile of the test item following intravenous infusion and to generate the nonclinical safety data required to support a first-in-human clinical trial and subsequent clinical development. The program shall be conducted in accordance with applicable regulatory requirements and guidelines and shall generate data and documentation suitable for regulatory submissions in the European Union and the United States. Particular attention shall be given to the assessment of renal safety, including the characterization of potential effects of both the test item and the vehicle on renal function and renal toxicity. In addition, the program includes the toxicological assessment of the test item following dermal administration to support the potential clinical evaluation of a semisolid formulation for topical administration. The dermal program is behind a Go/No-Go decision.
Key facts
Each fact is from the official notice, last checked 26 October 2026, 15:47 (UTC+01:00).
- Status
- OpenOfficial notice · checked 26 Oct 2026, 15:47 (UTC+01:00)
- Deadline
- (in 30 days)Official notice · checked 26 Oct 2026, 15:47 (UTC+01:00)
- Buyer
- Helmholtz-Zentrum für Infektionsforschung GmbH, Braunschweig, DEOfficial notice · checked 26 Oct 2026, 15:47 (UTC+01:00)
- Place of performance
- Braunschweig, Kreisfreie Stadt (DE911)Official notice · checked 26 Oct 2026, 15:47 (UTC+01:00)
- Main CPV
- Research and experimental development services (CPV 73100000)Official notice · checked 26 Oct 2026, 15:47 (UTC+01:00)
- Procedure
- OpenOfficial notice · checked 26 Oct 2026, 15:47 (UTC+01:00)
- Lots
- 1Official notice · checked 26 Oct 2026, 15:47 (UTC+01:00)
- First published
- 23 October 2026, 15:59 (UTC+02:00)Official notice · checked 26 Oct 2026, 15:47 (UTC+01:00)
Fact sheet
Lots (1)
Lot LOT-0001: Non-Clinical toxicology and safety assessment of a small molecule
The overall objective of the present project is to conduct a comprehensive nonclinical toxicology and safety assessment program for a small-molecule drug candidate. The program is intended to characterize the toxicological and safety pharmacology profile of the test item following intravenous infusion and to generate the nonclinical safety data required to support a first-in-human clinical trial and subsequent clinical development. The program shall be conducted in accordance with applicable regulatory requirements and guidelines and shall generate data and documentation suitable for regulatory submissions in the European Union and the United States. Particular attention shall be given to the assessment of renal safety, including the characterization of potential effects of both the test item and the vehicle on renal function and renal toxicity. In addition, the program includes the toxicological assessment of the test item following dermal administration to support the potential clinical evaluation of a semisolid formulation for topical administration. The dermal program is behind a Go/No-Go decision.
Timeline
- 23 October 2026, 15:59 (UTC+02:00): Original notice Notice, version 01 (Contract or concession notice – standard regime). Official notice
Buyer and place
Buyer
Helmholtz-Zentrum für Infektionsforschung GmbH
Braunschweig, DE
Place of performance
- Braunschweig, Kreisfreie Stadt (DE911)
Classification
CPV codes
- 73100000: Research and experimental development services
- 73110000: Research services
- 73111000: Research laboratory services
- 73120000: Experimental development services
NUTS regions
- DE911: Braunschweig, Kreisfreie Stadt
Official documents
Links go to the publisher. Inteliwert does not copy the documents.
Questions and answers
When is the deadline?
The official notice gives 7 December 2026, 10:00 (UTC+01:00) as the deadline.
Who is the buyer?
Helmholtz-Zentrum für Infektionsforschung GmbH, Braunschweig, DE.
What is being procured (CPV)?
Research and experimental development services (CPV 73100000), Research services (CPV 73110000), Research laboratory services (CPV 73111000) and Experimental development services (CPV 73120000).
Where is the work performed (NUTS)?
Braunschweig, Kreisfreie Stadt (DE911).
Is it divided into lots?
No, the notice names a single lot.
Which procedure is used?
Open.
How do I submit a bid?
On the official notice or the portal it names. Inteliwert does not submit bids. Official notice
Am I eligible?
Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice
Companies that might fit
Possible match based on public information
Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.
- SME (from the award notice)New to public tenders
ING3D GmbH
FürthSME (from the award notice)New to public tenders- SME (from the award notice)New to public tenders
Guidehouse Germany GmbH
BerlinSME (from the award notice)New to public tendersPrognos AG
BerlinEstablished supplierNew to public tenders
More from this buyer
Other published opportunities of this buyer in the indexed notices, open ones first.
-
AwardedTender
Neubau HIPSII.2: VE03.05 - Rohbauarbeiten
Last checked 27 Oct 2026, 06:30 (UTC+01:00)Official notice
Source
- Publisher
- Bekanntmachungsservice
- Licence
- CC0 1.0
- Last checked
- 26 October 2026, 15:47 (UTC+01:00)
The official notice is authoritative. Inteliwert shows what the notice states and links to it.